LOS ANGELES, CA, May 21, 2024 – (ACN Newswire) – In a legendary feat of craftsmanship and “stoner ingenuity,” Tommy Chong, celebrated comedian, actor, and icon, has shattered the world record for smoking the largest handcrafted blunt. The previous record stood at just over five pounds, but Chong, along with world-class rollers Dawn “Grasshoppa” Doan and June Da Goon, champions of both the World Rolling Championship and the National Joint League, achieved the unimaginable with a 23.36-pound blunt containing a colossal 21 pounds (9,555g) of marijuana. The monumental event coincides with Tommy Chong’s 86th birthday later this week, making it a double celebration for the cannabis community and fans worldwide.

The event was a testament to the passion and dedication of the cannabis community. Dawn “Grasshoppa” Doan, the world’s first professional female roller, Rolling Champion, and judge, featured in Forbes, High Times, and Vice magazine, expressed her excitement. “It’s moments like this that make all the years of rolling worth it. June and I have been rolling professionally for over 10 years, and to be part of such a historic achievement with a legend like Tommy is beyond words.”

June Da Goon, a five-time rolling champion featured in High Times magazine and on Leafly, highlighted the uniqueness of this blunt. “Most blunts over a couple pounds have to be hooked up to a fan blower. At 20 pounds, this was a feat beyond measure to rip huge clouds using nothing but lung power. There may have been other big rolls, but they didn’t smoke.”

James Alexander, a key organizer of the event, emphasized the significance of its non-commercial nature. “This was a non-sponsored event, completely free of commercialization. It was important for us to do this for the love of the plant and the community. We wanted to celebrate cannabis culture in its purest form, and I believe we succeeded.”

Chong commented on the achievement and its recognition. “The Guinness Book of Records might not be ‘honoring’ cannabis-related records right now, but I know in my heart we set the record here today. It was an honor to take the first toke. Plus, who needs to be in a record book when you’ve got a blunt this big?”

The historic smoke out, captured on video, showcases the spirit of unity and creativity within the cannabis community. Fans and enthusiasts can witness the record-breaking moment and join the celebration by watching the video on YouTube.

As Tommy Chong turns 86 on May 24, his enduring influence and love for the plant continues to inspire. This record-breaking event not only honors his contributions to the culture but also highlights the vibrant and innovative spirit of the community as a whole.

For more information and to see more exclusive Cheech & Chong content, visit Bowlmates.com.

Source: Cheech and Chong’s Cannabis Company

Copyright 2024 ACN Newswire. All rights reserved. http://www.acnnewswire.com

SHENZHEN, CHINA, Jul 26, 2023 – (ACN Newswire) – With the continuous iteration and advancement of electronic cigarette technology, the latest concept of disposable electronic cigarettes, dual mesh coil, has attracted attention. As the pioneer of high-capacity dual mesh coil technology, VapeEZ always keeps in mind the mission of "Vaporization technology changing lifestyle" and has launched groundbreaking NEXCORE Dual Boost, the first platform to adopt high-capacity dual mesh coil technology for double cloud and greater taste in the market. With outstanding technological innovation capabilities, VapeEZ collaborates with brand partners to take the lead in the field of electronic vaporization for maximized puffs and help customers achieve commercial success.

The idea of Nexcore Dual Boost was born three years ago, and after more than 800 days of research and over 20,000 analytical experiments, it has finally been introduced. It has already acquired 90% of the invention patents and utility model patents in this field, representing the cutting-edge technology in the electronic vaporization industry.

Unlike the common dual mesh configurations on the market, Nexcore Dual Boost breaks away from the traditional top-and-bottom structure and offers a unique mode that not only satisfies users' ultimate taste experience but also caters to the pursuit of large capacity and high puff counts. It provides a perfect solution for balancing taste and capacity, making it more suitable for high-capacity and maximized puff atomizers, showcasing an exciting and cost-effective option with as twice as much cloud and taste experience.

NEXCORE DUAL BOOST, an intelligent dual mesh cutting-edge technology, strives for providing an all-round solution to double both the cloud and taste experience. It has a faster heating start-up speed, stable and uniform heating, and significantly improved heating efficiency. It extends the lifespan of the heating coil and greatly improves the utilization of juice, truly satisfying the desire for dense vapor inhalation. It restores delicate flavors that never fade, ensuring a longer and upgraded taste experience.

Equipped with NEXCORE DUAL BOOST dual mesh products, known for their originality and high cost-effectiveness, they continuously double full-bodied vapor, restoring a genuine and rich taste, ensuring consistent and delicate flavors. As a first-striking mature dual mesh technology, it quickly captures the market with a potential shipment volume of up to 20 million and a production efficiency improvement of 99%.

About VapeEZ

VapeEZ, as an experienced manufacturer of closed-system pod mods and disposable vapes, is the first to provide a high-capacity dual mesh technology solution. It has established the Qingdao Research Institute and a laboratory in the United States, conducting in-depth research in materials, chemistry, biology, electronics, and other fields. With innovation as its technological gene and user experience as its R&D orientation, VapeEZ continuously brings higher-quality vaporization experiences to users. All the goodness begins with the "core".

For more information about brand and products, please visit official website at https://myvapeez.com/?nexcore-dual-boost/.

Business Contact: marketing@myvapeez.com

Media Contact
Fiona Wang, Shenzhen VapeEZ Technology LTD
Shenzhen, Guangdong, China
Email: marketing@myvapeez.com
Tel: +8617322371918
Website: https://myvapeez.com/?nexcore-dual-boost/

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

TUCSON, AZ, May 18, 2023 – (ACN Newswire) – WEED Inc. (OTCQB:BUDZ), ("WEED" or the "Company") a global cannabis & hemp bioresearch company based in the USA, focused on the development and application of cannabis-derived compounds for the treatment of human and animal diseases.

Wholly owned subsidiary HEMP Biosciences Inc. is pleased to announce that it received its hemp cultivation license from the state of Arizona. The license allows for cultivation, process and manufacture of hemp for the production of low THC & CBD products.

In addition, Ms. Brunskill-Scott has been appointed as our in-house counsel for both WEED Australia Limited and the Cannabis Institute of Australia. While Mr. Patrick Brodnik, will continue to promote the Corporate Business Development for WEED Inc. USA and continue working on strategic partnerships and cannabis acquisitions for WEED Australia Limited.

We would like to take this opportunity to express our heartfelt gratitude to Mr. John J. Foley, who recently retired from our Australian management & Board of Directors. Glenn E. Martin CEO comments, "John has been a faithful servant to our company since the beginning, and we wish him a well-deserved retirement at the young age of 85 years old. We look forward to his continued advice and counsel in the future."

Ms. Brunskill-Scott is an advocate for the indigenous peoples of Australia and grew up in the Northern Territory, as her family is both indigenous Australians and from Papa New Guinea. Her appointment to our Board of Directors reflects our commitment to diversity and inclusion, and we are excited to have her leadership and vision driving our company forward. Darwin and the Far Northern Territories such as Cape York which are top of our list for cannabis cultivation.

Ms. Brunskill-Scott announces, "I'm excited and privileged for the opportunity before me to lead the team WEED Australia has established over the past 7 years. Surviving Covid hardships has strengthened our resolve to find natural plant remedies to complex medical conditions. WEED Australia and the Cannabis Institute looks to lead the charge in cannabis research and product development making it affordable to all compared to the current market situation."

Mrs. Breen states, "The cannabis industry in Australia is on the global forefront. WEED was incorporated in March 2017 as an ASIC regulated entity. Post Covid WEED looks to ready an IPO for the ASX once economic condition warrants. I am excited to work with Amanda and bring WEED Australia to its full potential in the cannabis and hemp space.

WEEDs key to success is our rare Landrace cannabis genetics grown and kept F-1 grade over 40-50 years, while scientific research and development will ensure year over year returns for our investors as we build a premier cannabis company in Australia."

WEED Australia Ltd is dedicated to developing innovative products and services for the Australian people utilizing the amazing cannabaceae plant.

Our nonprofit arm, the Cannabis Institute of Australia, is focused on cannabis & hemp research including clinical trials for pharma and non-pharma product and services.

With the appointment of Ms. Brunskill-Scott and Mrs. Breen, we are confident that WEED Australia Limited as a majority owned subsidiary of WEED Inc (USA) will continue to grow and thrive as a global cannabis holding company. WEED Australia Ltd. formed in March 2017 was the first cannabis pubco, ASIC regulated, in Australia with an American parent.

WEED, Inc.'s Subsidiaries past comments:

WEED Israel (Cannabis) Ltd. "After over 3 years of putting human clinical trials and product development on hold due to COVID, WEED Israel is poised and anxious to build out our global brands in both pharmaceutical and non-pharmaceutical categories, starting with women's health and veterans' ailments (PTSD) to healthy green alternative medicines" stated Elliot Kwestel, Managing Director of WEED Israel (Cannabis) Ltd. based outside Jerusalem.

Kwestel further commented, "WEED Israel looks to enrich and expand our clinical trials with both THC and Cannabinoid studies to promote healthy living for generations to come."

WEED Australia Ltd. and The Cannabis Institute of Australia (C.I.A.), our Australian non-profit arm, based in Queensland on the Gold Coast.

Corporate Director Patrick Brodnik stated, "With the new rules out governing cannabis & hemp in Australia and the announcement in February 2021 to allow over-the-counter CBD medicines in pharmacies, now after Covid, timing is perfect to begin our clinical trials in Israel and Australia to bring new curative products to market as we close out COVID mandates this year.

Managing Director Brunskill-Scott commented "Next year 2024, the future of USA & Australia decriminalizing cannabis and hemp globally will prove to be a giant leap forward for worldwide cannabis legalization."

WEED Hong Kong Ltd. Director Nicole Breen agrees, "The pandemic has affected all of us on a worldwide basis. Healing our planet with natural therapies, treatments and eventual "cures" utilizing natures' own Cannabaceae plant with its many properties, both with high tetrahydrocannabinol (THC) and cannabidiol (CBD) compounds, I believe will change the force of medicine forever in the years to come. We look forward to an exciting year end and a Prosperous 2022.

Caution Regarding Cannabis Operations in the United States:

Any Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. While legal in certain states, cannabis remains a Schedule I drug under the U.S. Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute, or possess cannabis.

That all Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable U.S. federal money laundering legislation. That Investors should carefully read the risk factors and disclosures contained in our offering circular before making any decision to invest in our company.

Forward Looking Information:

This news release contains "forward-looking information" within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, "may", "potential", "would", "could", "will", "likely", "expect", "anticipate", "believe, "intend", "plan", "forecast", "project", "estimate", "outlook" and other similar expressions, and include statements with respect to any future revenue and profits.

Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management's experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct.

Actual results and developments may differ materially from those contemplated by these statements.

Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. The statements in this press release are made as of the date of this release.

That the Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws for the relevant country.

Legal Notice:

That the information is provided for convenience only, it is not investment advice and may not be relied upon in considering an investment in WEED, Inc.

That No representation or warranty, express or implied, is made as to the accuracy or completeness of any information contained herein, and any investment decision should be based solely on the information contained in the offering circular and related materials, and the investors independent research.

We advise that No representations or warranty, express or implied, is made as to the future performance of any investment in WEED, Inc. or that investors will or are likely to achieve favorable results, will make any profit at all or will be able to avoid incurring a loss on their investment.

In addition, all prospective investors are encouraged to consult with their financial, tax, accounting, or other advisors to determine whether an investment in WEED, Inc. is suitable for them.

Media Contact:
Glenn E. Martin, CEO
1-520-818-8582
Glenn@WEEDincUSA.com

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

PETALING JAYA, Malaysia, Feb 24, 2023 – (ACN Newswire) – Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today announced that the Group has entered into a strategic collaboration with Kensana Health Canada and MAHSA University for the research and development (R&D) of phytopharmaceutical and biotechnology products that can lead to commercialisation.

Kensana Health Canada is a biotechnology specialist focused on the R&D of cannabinoid treatments and management of wounds partnered with a German multinational phytopharmaceutical company. MAHSA University is a private Malaysian university focused on allied health sciences with a 48-acre campus in Bandar Saujana Putra, Selangor and a diverse population of students from 75 countries.

The strategic collaboration involves all three parties conducting joint R&D on species improvement, identification, formulation and pre-clinical testing of novel phytocompounds with potential therapeutic and commercial value, among other areas.

Dato' Alvin Joseph Nesakumar, Executive Director of Malaysian Genomics said, "The Group welcomes this strategic collaboration with MAHSA and Kensana to expand R&D activities utilising plant-based formulations to produce results that can be commercialised in countries where the law allows the use of cannabinoid medications. In Malaysia, there are also moves to register cannabidiol products this year."

"We have the market knowledge and expertise in the distribution of healthcare-related products while our track record of collaborations and partnerships will help support the Group's focus on the biopharmaceuticals business for growth and sustainability. We also have necessary lab equipment to support the R&D efforts."

Mr. Ken Clement, Chairman and CEO of Kensana Health Canada said, "We look forward to working with Malaysian Genomics and MAHSA by providing our technology and knowledge in advancing the R&D efforts. We have the proprietary knowledge as well as the proven techniques in standardised cannabinoid crops and recipes and have a unique approach to wound management where we are a worldwide leader."

Dato' Dr. Shahril bin Tan Sri Prof. Datuk Haniffa, Group Managing Director of the MAHSA group of companies and MAHSA University said, "This collaboration brings together parties with expertise and knowledge in their fields that we look forward to working and sharing with in areas that the university is interested to see expanded on. Besides identifying novel bioactive compounds with potential therapeutic uses, the collaboration includes offering education and training programmes to stakeholders, inclusive of health professionals, educational institutions and hospitals that is also an important component of advancing the health sciences."

Malaysian Genomics Resource Centre Bhd: 0155 [BURSA: MGRC] [RIC: MGRC:KL] [BBG: MGRC:MK], http://www.mgrc.com.my/

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Perth, Australia, Vancouver, British Columbia and Greenville, North Carolina, Nov 3, 2022 – (ACN Newswire) – WestCann Holdings Ltd. (“WCH” or the “Company”) is pleased to announce that it has signed an agreement with IOTO USA, LLC (“IOTO”) for the exclusive global licensing of all uses with cannabis and hemp of IOTO’s patented technologies for the reconstitution of plant matter.

Originally developed for the primary processing of tobacco, IOTO’s technologies allow for complete homogenization of cannabis as well as for full process control over the active ingredients and smoking characteristics. As a result, precision tobacco cigarette making and packaging equipment can be utilized for pre-roll manufacturing, creating a highly consistent and reproducible consumer product with significant quality and cost advantages.

The Company’s wholly owned subsidiary WestCann Processors Inc. is planning to start the manufacturing of reconstituted cannabis pre-rolls for the Canadian recreational market at its Yorkton, SK facility by December 2022 and expects its products to be available to consumers through licensed retail stores in early 2023.

CEO Andreas Gedeon: “I’m convinced that our products will be disruptive to the existing pre-roll market, which is one of the single biggest growing segments in the cannabis industry. I believe that consumers will quickly appreciate our convenient format and the fact that they can always get the same experience with the next pack they purchase, all at a discount to what they are used to paying right now.”

The exclusive license to IOTO’s technologies complements WestCann’s portfolio of custom engineered automatization solutions, including its patented child resistant hinge lid pack that is certified for use in Canada, the U.S., Switzerland and the EU.

Over the course of the next year, the Company plans on partnering with licensed operations in several U.S. states for additional installations of its fully automated pre-roll making and packing lines, as well as on preparing to be a first mover in the upcoming recreational cannabis markets in Germany and Thailand.

For further information please visit www.westcann.com or contact Andreas Gedeon, CEO at andreas@westcann.com.

About WestCann

WestCann Holdings Ltd., based in Perth, WA and its wholly owned subsidiaries WestCann Processors Inc, 102021671 Saskatchewan Inc. in Canada and Laika Brands, LLC in Nevada are focusing on the transfer of tobacco processing technologies to the recreational cannabis markets. For more information on WestCann please visit www.westcann.com.

About IOTO

IOTO USA, LLC, a subsidiary of IOTO International in Brazil, is a global leader in the provision of flavorings and reconstitution technologies for tobacco. For more information on IOTO please visit www.iotointernational.com.

PRESS RELEASE CONTACT
Andreas Gedeon
+1 (250) 713-6302
andreas@westcann.com

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Arizona, Aug 31, 2022 – (ACN Newswire) – One of the greatest hurdles in the Web3 space is creating opportunities without creating violations; we set out to bring ownership of a cannabis company to our holders and we were determined to do it in a way that didn't bring forth securities violations and ensure longevity and sustainability are our primary focus.

We've created Half BAYCD as an opportunity for our pass holders to either license their own BAYC/MAYC/BAKC/Koda or partner with a holder and do a revenue share on the licensing of the IP.

By leveraging the royalty structure we're able to offer a 50% net profit share agreement to be equally distributed amongst licensees for the brand, essentially 6,969 people become "owners" of a multi-national cannabis brand built around Web3 culture.

The variety of passes

We've gamified our passes to offer tiered benefits and fun to be a holder, we have 7 pass tiers, all of which allow licensing to the cannabis brand.

BAYCD Pass: The BAYCD Pass allows you to license an asset, or partner with an asset holder to co-license the asset to the Half BAYCD brand. The BAYCD Pass shares a 30% participation pool.

Stoner Pass: The Stoner Pass carries the same benefits as the BAYCD Pass but also grants 20% off of Half BAYCD products at retail partners and our online store. The Stoner Pass shares the same 30% participation pool as above.

420 Pass: The 420 Pass brings with it the same licensing opportunities and 20% cannabis discounts but also adds a quarterly cannabis care package that will be claimable in participating licensed regions. The 420 Pass shares the same 30% participation pool as above.

Merch Pass: The Merch Pass brings with it the same licensing opportunities and 20% cannabis discounts but also adds a quarterly merch care package that will be redeemable on our e-commerce store with each new drop. The Merch Pass shares the same 30% participation pool as above.

Pack Pass: The Pack Pass brings forth a new licensing opportunity as well as its own unique 10% participation pool that is divided amongst the lucky 420 that hold one. Our Pack Pass guarantees that your asset will be used on packaging/branding.

Club Pass: The Club Pass has a unique advantage in which you have direct involvement in the brand curation and development — this pass doesn't require licensing to receive a participation share. The Club Passes have their own 10% participation pool shared amongst the 100 lucky holders.

Pheno Pass: The Pheno Pass is for the lucky chosen few, there are only 10 of them to be minted — the Pheno Pass doesn't have a shared participation pool but rather takes you on a journey. You will be able to pheno hunt and create your own genetics which you then license to us for use.

Wen product

We've been working on our packaging and branding for the last 6 months, packaging design work should be finalized at the end of August and production will take roughly 6 weeks.

Our initial launch cities will be LA, Denver, Vegas, and NYC – we are an ancillary goods company, we're non-plant touching and that enables us to insulate our holders from the cannabis industry regulations.

We're excited for the forthcoming announcement that outlines our production partners in each location and the value-add that they bring to the brand.

We also own equity in the patents for sublingual strips with cannabinoids, it's one of the flagship products that we are excited to bring to market. We handed out thousands of them during NFT NYC and received amazing feedback and debuted the first time that Kodas have been licensed to physical goods.

Wen mint

Our mint is currently live, we have 6969 passes that are minting at .069E — if you're interested in joining the Half BAYCD family, you can mint at halfbaycd.com.

If you have questions on the project or would like to learn more, we welcome you to join us on Twitter at @halfbaycd and also in discord at discord.gg/halfbaycd.

Source: Plato Data Intelligence: Platodata.ai

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com